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Increased requirement for minute ventilation and negative arterial to
end-tidal carbon dioxide gradient may indicate malignant hyperthermia
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Received November 29, 2011; accepted July 6, 2012AbstractCharacteristic signs of malignant hyperthermia (MH) include unexplained tachycardia, increased end-tidal carbon dioxide (EtCO2) con-
centration, metabolic and respiratory acidosis, and an increase in body temperature above 38.8C. We present the case of a patient with highly
probable MH. In addition to sinus tachycardia and metabolic and respiratory acidosis, this patient also had a negative arterial to EtCO2 gradient
and an increased requirement for minute ventilation to maintain a normal EtCO2 concentration, with signs of increased CO2 production. Despite
these signs of MH, the patient’s rectal temperature monitoring equipment did not show an increase in temperature, although the temperature
measured in the mouth was increased. This case illustrates the unreliability of measuring rectal temperature as a means of reflecting body
temperature during MH and the usefulness of increased CO2 production signs in helping to diagnose MH.
Copyright  2014 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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A rapid increase in end-tidal carbon dioxide (EtCO2) is one
of the earliest signs of an episode of malignant hyperthermia
(MH).1 However, increased EtCO2 may not present with an
increased minute ventilation (MVe)2,3 or may be neglected due
to normal arterial carbon dioxide concentrations (PaCO2).
4
Under these circumstances, a negative gradient between
PaCO2 and EtCO2 [(a-Et)PCO2], another early sign of MH, can
be used as an additional diagnostic indication.4 We present
here a clinically “almost certain” case of MH. An earlier
diagnosis of MH could have been made if we had used an
increased MVe and negative (a-Et)PCO2 as signs of MH.Conflicts of interest: The authors declare that there are no conflicts of interest
related to the subject matter or materials discussed in this article.
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A 71-year-old woman weighing 64 kg with a body mass
index of 26 and of American Society of Anesthesiologists
physical status II was scheduled for the excision of a thoracic
spine T1e2 neurogenic tumor. The patient had no previous
exposure to general anesthesia. There was no known family
history of MH or myopathies. She had a history of asthma with
no recent attack and drug treatment had been stopped 2 years
previously. A preoperative pulmonary function test showed
mild restrictive ventilatory impairment with a forced expira-
tory volume in the 1st second of expiration of 1.47 L (78% of
predicted value).
Anesthesia was induced with fentanyl, propofol, and cis-
atracurium. After uneventful endotracheal intubation, a radial
arterial catheter, a central venous catheter via the internal ju-
gular vein, and a rectal temperature probe were inserted.
Anesthesia was maintained with isoflurane in an oxygen and
air mixture. The patient’s temperature was 36.0C and herhinese Medical Association. All rights reserved.
Table 1
Sequential data at different time points for this patient.
Time after induction of anesthesia (min)
70 160 180 210 240 290
pH 7.381 7.266 7.240 7.108 7.004 7.467
PaCO2 (mmHg) 36.4 37.7 44.7 75.3 107.7 33.5
EtCO2 (mmHg) 33 47 57 92 99
a NA
(a-Et)PCO2 (mmHg) 3.4 9.3 12.3 16.7 NA NA
Kþ (mmol/L) 3.43 4.19 3.93 3.93 4.92 5.0
Temperatureb (C) 36.0 36.5 36.8 36.8 37.2,b 38.4c 37.1d
MVe (L/min) 5.3 8.0 8.0 8.0 10.0 9.0
(a-Et)PCO2 ¼ gradient between PaCO2 and end-tidal CO2; EtCO2 ¼ end-tidal
CO2; MVe ¼ minute ventilation; NA ¼ not applicable; PaCO2 ¼ arterial carbon
dioxide concentrations.
a Upper measurement range of capnography.
b Rectal temperature.
c Oral temperature.
d Tympanic membrane temperature.
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ately after induction (Fig. 1). The airway pressure was
24 cmH2O and the dynamic respiratory compliance was
25.33 mL/cmH2O.
The patient was placed in a prone position about 1 hour
after the induction of anesthesia. After the change to a prone
position, her airway pressure increased and the ventilator was
switched to pressure control mode, with the inspiratory pres-
sure set at 24 cmH2O; respiratory compliance dropped to
20.48 mL/cmH2O. During the next hour, MVe was gradually
increased from 4.7 L/minute to 8.0 L/minute by increasing the
inspiratory pressure setting to 28 cmH2O and increasing the
respiratory rate to 14 per minute to keep the EtCO2 around
40 mmHg. The patient’s respiratory compliance was
22.80 mL/cmH2O and her temperature remained at 36.1
C
during this period.
In the next 30 minutes, the EtCO2 gradually increased to
47 mmHg with an increase in heart rate to 100 beats per
minute (bpm) and decreased blood pressure (systolic blood
pressure around 90 mmHg). At this time, the patient’s tem-
perature was 36.5C. There was an estimated concurrent blood
loss of 1200 mL. Colloid and blood products were used for
replacement. Arterial blood gas (ABG) analysis showed
metabolic acidosis (base excess, BE ¼ e10 mmol/L) with a
pH of 7.27, PaCO2 37.7 mmHg, and a negative (a-ET)PCO2
gradient (Table 1; Fig. 1). Sodium bicarbonate was given to
correct acidosis. Over the next 20 minutes the EtCO2 continued
to increase to 57 mmHg. MH was highly suspected, although
the rectal temperature was only 36.8C. Subsequent ABG
analysis showed a more significant negative (a-ET)PCO2
gradient, with pH 7.24, PaCO2 44.7 mmHg, and BE 8 mmol/
L (Table 1). We checked whether the temperature probe was in
the correct position. The gas analysis machine, CO2 absorber,Fig. 1. Minute ventilation and end-tidal CO2 (EtCO2) versus time. Time starts at
induction of anesthesia. The patient was relatively stable for about 80 minutes,
but minute ventilation (MVe) was gradually increased to maintain EtCO2 (point
a to b). Increasing EtCO2 was then noted in spite of the increased MVe (8.0 L/
minute), whereas the arterial CO2 concentration remained normal (point b).
EtCO2 increased rapidly later, and malignant hyperthermia was diagnosed
(point c). Dantrolene was infused and the patient remained hemodynamically
stable, whereas EtCO2 stayed at the high extreme (point d).and breathing circuit were checked to exclude equipment
error. During the checking, the breathing circuit was found to
be very warm and humid and the EtCO2 was increased rapidly
to 92 mmHg. The ABG results were pH 7.108 and PaCO2
75.3 mmHg (Table 1; Fig. 1). Her heart rate was 130 bpm. The
diagnosis of MH was made and treatment commenced
immediately. At this time, the patient’s rectal temperature still
showed 36.8C despite correct positioning having been
confirmed.
Isoflurane was withdrawn immediately. Anesthesia was
maintained with propofol infusion. The anesthetic machine
was replaced and the patient’s lungs were hyperventilated with
100% O2. Rapid infusion of dentrolene was started at a dose of
2 mg/kg. The operation ended 30 minutes later and the patient
was returned to a supine position. Her oral temperature was
38.4C, whereas the rectal temperature equipment still read
37.2C. Her heart rate decreased progressively from 145 bpm
to 115 bpm after the dantrolene infusion. Nevertheless, the
EtCO2 was more than 99 mmHg (the upper measurement limit
of the capnograph), with blood gas analysis showing pH 7.004
and PaCO2 107.7 mmHg (Table 1; Fig. 1). The patient was
admitted to the intensive care unit (ICU) under stable hemo-
dynamic conditions.
On arrival in the ICU, the patient’s tympanic temperature
was 39.0C. Ice water irrigation via a nasogastric tube and an
alcohol bath were used to cool the patient. Her temperature
and PaCO2 shortly returned to normal. ABG analysis showed
pH 7.467, PaCO2 33.5 mmHg, BE 0.3 mmol/L and K
þ
5.0 mmol/L. Her tympanic temperature was 37.1C 45 mi-
nutes after being admitted to the ICU. Her creatinine kinase
peaked at 107 U/L during the morning of the 1st postoperative
day. The patient was extubated on the 1st postoperative day
and was closely monitored for another 24 hours. There was no
further sign of MH and no additional dantrolene was given in
the ICU. The patient was discharged from hospital 6 days later
with an uneventful postoperative course. The patient and her
family had been informed of possible MH during anesthesia
and surgery, but she had not undergone a muscle biopsy test.
According to the clinical grading scale of MH, the patient’s
211H.-T. Lin et al. / Journal of the Chinese Medical Association 77 (2014) 209e212score was 58, which places her in the highest probability
category of “almost certain”.5
3. Discussion
This case illustrates several interesting points. Firstly, an
initial increase in EtCO2 can be masked by increased MVe.
Secondly, negative (a-Et)PCO2 can be present in spite of a
relatively normal PaCO2. Thirdly, rectal temperature moni-
toring may not be a reliable method of detecting changes in
body temperature during MH. In this patient, increased EtCO2
was seen early during anesthesia. However, definite treatment
was not given immediately due to the relatively normal PaCO2,
concern about possible equipment error, and inaccurate body
temperature measurement. Under such circumstances, the
measurement of body temperature at a different site and a
negative (a-Et)PCO2 or venous blood gas analysis of PCO2, or
both, should be useful in making an early diagnosis.
An increase in EtCO2 is one of the earliest signs of MH.
Although continuous capnographic monitoring is cited as a
means of detecting this sign of an MH episode, increased MVe
can confound the interpretation of the capnographic data.
Increased MVe can initially normalize the increased EtCO2.
This process can confuse the clinical picture and may delay
the diagnosis of MH. This situation is especially difficult to
recognize during lapascopic procedures.2,3 In our patient, the
gradual adjustments of MVe to maintain normocarbia in the
early period (Fig. 1) might have helped to mask increasing
CO2 production and delayed the diagnosis of MH. Although
the increased physiological dead space could also explain
increased MVe, the possibility was excluded due to there being
no significant change in lung compliance during this period.
This case illustrates the necessity for EtCO2 to always be
evaluated in conjunction with MVe. When the MVe require-
ment exceeds the predicted MVe requirement, further inves-
tigation is necessary, even when the capnographic data are
within the normal range. If all other sources of increased MVe
requirement are excluded, an increased central venous CO2 to
PaCO2 gradient may help to indicate the diagnosis of MH.
6,7
Kwetny and Finucane4 first described the phenomenon of
negative (a-Et)PCO2 gradient during an episode of MH.
Negative (a-Et)PCO2 values were first observed during anes-
thesia more than 50 years ago by Nunn and Hill.8 Thereafter,
this phenomenon was noticed in pregnant women, infants, and
small children during anesthesia.9,10 Factors such as increased
cardiac output and CO2 production, low total lung compliance,
and reduced functional residual capacity are responsible for
this phenomenon.11 Patients with an MH episode have
increased cardiac output and CO2 production. The PCO2 of
most alveolar gas is less than PaCO2, but in the terminal part of
the expirate, the alveolar PCO2 may increase rapidly toward
mixed venous PCO2 and exceeds PaCO2 in the presence of MH
because a large amount of CO2 is discharged into the lungs.
Increased cardiac output and pulmonary blood flow result in
better perfusion of the alveoli and facilitate the increase in
EtCO2. Thus the capnogram’s Phase III slope increases, and
this part of the PCO2 concentration is more likely to besampling venous CO2 (PvCO2) rather than PaCO2.
11 Therefore a
negative (a-Et)PCO2 can be an early sign of MH and be used as
a diagnostic and monitoring parameter during MH crisis.4
During the MH episode in our patient, the negative (a-Et)
PCO2 gradient (e9.3 mmHg) first appeared 160 minutes after
the induction of anesthesia (Table 1). Although other factors,
such as obesity (body mass index 26), a history of asthma with
impaired lung function, and prone position might have
contributed to the negative (a-Et)PCO2 gradient in our patient,
the venous CO2 concentration should be checked to confirm
the increase in CO2 production. Unfortunately, we did not
perform this examination. Based on this case, it is reasonable
to suggest that parameters such as (a-Et)PCO2, central venous
CO2 saturation (Scv CO2), and mixed venous CO2 saturation
(Sv CO2) that are heavily affected by CO2 production should
be more sensitive to the early detection of MH than those that
can also be influenced by CO2 elimination, i.e., EtCO2 and
PaCO2.
Hyperthermia is a later sign of MH and is typically absent
when the diagnosis is initially suspected. However, hyper-
thermia can also be missed with certain monitoring methods.
Core temperature measured at the pulmonary artery, distal
esophagus, tympanic membrane, or nasopharynx is a reliable
monitor when body temperature increases during MH. Some
of these measurements are invasive and may not be practical
in many instances.12,13 However, core temperature can be
estimated with reasonable accuracy using oral, axillary,
bladder, and rectal temperatures, except during extreme ther-
mal perturbations.12,13 Skin surface and rectal temperatures
are usually well correlated with core temperature, but may not
increase appropriately during MH crises.14 Bladder tempera-
ture is equal to rectal temperature when the urine flow is low,
but is equal to the pulmonary artery temperature when the
flow is high.15 In our patient, the rectal temperature was
measured due to its accessibility during neurosurgery. It
peaked at 37.2C prior to when the patient was sent to the
ICU. The tympanic membrane temperature measured on
arrival in the ICU was 39.0C. We used a Philips-Agilient
temperature monitor (Germany), which was maintained and
checked for accuracy by a Philips-qualified engineer every 3
months. No report of rectal temperature monitor malfunction
was noted. The inaccuracy of using rectal temperature as an
estimate of core temperature during an episode of MH in our
patient might be due to fecal insulation or relatively low
perfusion of the rectum during anesthesia.16 Thus we suggest
that rectal temperature should be interpreted carefully and
other temperature monitoring methods should be sought dur-
ing such episodes.
In conclusion, increased EtCO2 is an early sign of MH crisis,
but can often be masked by hyperventilation. Careful evalua-
tion of capnographic data in conjunction with MVe throughout
the course of the crisis is extremely important. Negative
arterial to EtCO2 gradient can be an early sign of MH, even
when PaCO2 is normal. An increased MVe in combination with
negative (a-Et)CO2 gradient may increase awareness of MH
during anesthesia and help in the earlier diagnosis of such
crisis.
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